| 2024-04-05 |
Age-standardised (world) incidence rates of the 33 leading cancers in the U.S., the European Union (EU-27), Sub-Saharan Africa, and China in 2022, all ages, both sexes combined |
|
|
| 2024-04-05 |
The enormous and continuing challenge of maintaining hope in patients with advanced cancer |
|
|
| 2024-04-05 |
Association of metformin use and cancer incidence: a systematic review and meta-analysis |
|
|
| 2024-04-05 |
RE: Supplemental magnetic resonance imaging plus mammography compared with magnetic resonance imaging or mammography by extent of breast density |
|
|
| 2024-04-05 |
Re: Incidence of in situ vs invasive melanoma: testing the “obligate precursor” hypothesis |
|
|
| 2024-04-05 |
Response to Omoleye, Esserman, Olufunmilayo |
|
|
| 2024-04-05 |
Response to Kahler, Janda, Soyer, et al. |
|
|
| 2024-04-05 |
Interventions addressing health-related social needs among patients with cancer |
|
|
| 2024-04-05 |
Hope during somber times: a defining moment |
|
|
| 2024-04-05 |
Colorectal cancer screening test exposure patterns in US adults 45 to 49 years of age, 2019-2021 |
|
|
| 2024-04-05 |
Correction to: Neoadjuvant BRAF-targeted therapy for ameloblastoma of the mandible: an organ preservation approach |
|
|
| 2024-04-05 |
Measuring prognostic awareness in patients with advanced cancer: a scoping review and interpretive synthesis of the impact of hope |
|
|
| 2024-04-05 |
Climate change perception and its association with cancer screening intent |
|
|
| 2024-04-05 |
Familial uveal melanoma and other tumors in 25 families with monoallelic germline MBD4 variants |
|
|
| 2024-04-05 |
Association of hearing loss with patient-reported functional outcomes in adult survivors of childhood cancer |
|
|
| 2024-04-05 |
Randomized trial of dyadic-report vs proxy-report and self-report symptom assessment for pediatric patients receiving cancer treatments |
|
|
| 2024-04-05 |
Exploring the cross-cancer effect of circulating proteins and discovering potential intervention targets for 13 site-specific cancers |
|
|
| 2024-04-05 |
Platinum ineligibility and survival outcomes in patients with advanced urothelial carcinoma receiving first-line treatment |
|
|
| 2024-04-05 |
Physical activity and checkpoint inhibition: association with toxicity and survival |
|
|
| 2024-04-05 |
Morphological diversity of cancer cells predicts prognosis across tumor types |
|
|
| 2024-04-05 |
Opioid tapering in older cancer survivors does not increase psychiatric or drug hospitalization rates |
|
|
| 2024-04-05 |
Long-term aspirin use and cancer risk: a 20-year cohort study |
|
|
| 2024-04-05 |
Neoadjuvant BRAF-targeted therapy for ameloblastoma of the mandible: an organ preservation approach |
|
|
| 2023-09-01 |
Centering patients with advanced cancer includes supporting their caregivers |
|
|
| 2023-09-01 |
Symptoms and early-onset colorectal cancer: red flags are common flags! |
|
|
| 2023-09-01 |
Interventions to improve outcomes for caregivers of patients with advanced cancer: a meta-analysis |
|
|
| 2023-09-01 |
Smoking status and the association between patient-level factors and survival among lung cancer patients |
|
|
| 2023-09-01 |
Target trial emulation to assess real-world efficacy in the Epidemiological Strategy and Medical Economics metastatic breast cancer cohort |
|
|
| 2023-09-01 |
The Pathways to Prevention program: nutrition as prevention for improved cancer outcomes |
|
|
| 2023-09-01 |
Response to Van Cauwenberge, Borremans, Van Houdt, et al. |
|
|
| 2023-09-01 |
RE: Systemic or vaginal hormone therapy after early breast cancer: a Danish Observational Cohort Study |
|
|
| 2023-09-01 |
Changes in cancer mortality after Medicaid expansion and the role of stage at diagnosis |
|
|
| 2023-09-01 |
Feasibility and value of genomic profiling in cancer of unknown primary: real-world evidence from prospective profiling study |
|
|
| 2023-09-01 |
Early mortality in patients with cancer treated with immune checkpoint inhibitors in routine practice |
|
|
| 2023-09-01 |
The intratumor microbiome is associated with microsatellite instability |
|
|
| 2023-09-01 |
Clinical development of new drugs for adults and children with cancer, 2010-2020 |
|
|
| 2023-09-01 |
Red-flag signs and symptoms for earlier diagnosis of early-onset colorectal cancer |
|
|
| 2023-09-01 |
Comparison of first-line radiosurgery for small-cell and non-small cell lung cancer brain metastases (CROSS-FIRE) |
|
|
| 2023-09-01 |
Clonal hematopoiesis in older patients with breast cancer receiving chemotherapy |
|
|
| 2023-07-28 |
Correction to: Randomized trial of First-Line tyrosine kinase inhibitor with or without radiotherapy for synchronous oligometastatic EGFR-Mutated Non-Small cell lung cancer |
|
|
| 2023-07-28 |
Correction to: ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications |
|
|
| 2023-07-28 |
Correction to: COVID-19 severity by vaccination status in the NCI COVID-19 and Cancer Patients Study (NCCAPS) |
|
|
| 2023-07-28 |
Making sense of the risks: what to tell adolescents and young adults diagnosed with cancer during pregnancy |
|
|
| 2023-07-28 |
RE: HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1 |
|
|
| 2023-07-28 |
RE: Heterozygous BRCA1 and BRCA2 and mismatch repair gene pathogenic variants in children and adolescents with cancer |
|
|
| 2023-07-28 |
Reply to Li and Colleagues |
|
|
| 2023-07-28 |
Reply to Bertucci, De Nonneville, and Finetti |
|
|
| 2023-07-28 |
Changes in survival in de novo metastatic cancer in an era of new medicines |
|
|
| 2023-07-28 |
Response to Song |
|
|
| 2023-07-28 |
Germline genetic variants and pediatric rhabdomyosarcoma outcomes: a report from the Children’s Oncology Group |
|
|
| 2023-07-28 |
RE: COVID-19 severity by vaccination status in the NCI COVID-19 and Cancer Patients Study (NCCAPS) |
|
|
| 2023-07-28 |
Risk prediction of hepatitis B or C or HIV among newly diagnosed cancer patients |
|
|
| 2023-07-28 |
Design of phase II oncology trials evaluating combinations of experimental agents |
|
|
| 2023-07-28 |
Overcoming the challenges to implementation of artificial intelligence in pathology |
|
|
| 2023-07-28 |
Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions |
|
|
| 2023-07-28 |
Adverse birth outcomes of adolescent and young adult women diagnosed with cancer during pregnancy |
|
|
| 2023-07-28 |
Linear association between radioactive iodine dose and second primary malignancy risk in thyroid cancer |
|
|
| 2023-07-28 |
Characteristics of patient navigation programs in the Cancer Moonshot ACCSIS colorectal cancer screening initiative |
|
|
| 2023-07-28 |
Use of menopausal hormone therapy and ovarian cancer risk in a French cohort study |
|
|
| 2023-07-28 |
Hysterectomy, bilateral oophorectomy, and breast cancer risk in a racially diverse prospective cohort study |
|
|
| 2023-07-28 |
Smoking as a prognostic factor for survival in patients with disseminated germ cell cancer |
|
|
| 2023-07-28 |
Medicaid expansion, chemotherapy delays, and racial disparities among women with early-stage breast cancer |
|
|
| 2023-07-28 |
Historical redlining and breast cancer treatment and survival among older women in the United States |
|
|
| 2023-07-28 |
Racial disparities in diagnostic evaluation of uterine cancer among Medicaid beneficiaries |
|
|
| 2023-07-28 |
The association of Medicaid expansion and pediatric cancer overall survival |
|
|
| 2023-07-28 |
Expression of Concern to: Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer |
|
|
| 2023-07-28 |
Should We Target Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer With Radiotherapy Before Administering Targeted Systemic Therapy? |
|
|
| 2023-07-28 |
Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer |
|
|
| 2023-02-10 |
Association of longer telomere length in cancer cells and cancer-associated fibroblasts with worse prognosis |
|
|
| 2023-02-10 |
RE: Use of straighteners and other hair products and incident uterine cancer |
|
|
| 2023-02-10 |
RE: Sociodemographic survival disparities for lung cancer in the United States, 2000-2016 |
|
|
| 2023-02-10 |
Response to Etminan |
|
|
| 2023-02-10 |
Correction to: Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy |
|
|
| 2023-02-10 |
Reply to Evans and Woodward |
|
|
| 2023-02-10 |
RE: Heterozygous BRCA1/BRCA2 and mismatch repair gene pathogenic variants in children and adolescents with cancer |
|
|
| 2023-02-10 |
Ultra-processed food consumption and risk of colorectal cancer precursors: results from 3 prospective cohorts |
|
|
| 2023-02-10 |
Ultra-processed foods and colorectal neoplasia: is there a link? |
|
|
| 2023-02-10 |
Improving precision oncology through better designs and reporting of biomarker-driven randomized clinical trials |
|
|
| 2023-02-10 |
Design and reporting of phase III oncology trials with prospective biomarker validation |
|
|
| 2023-02-10 |
Body mass index and molecular subtypes of colorectal cancer |
|
|
| 2023-02-10 |
Combined individual participant data: highest-level evidence on obesity and colorectal cancer molecular subtypes |
|
|
| 2023-02-10 |
RE: Systemic or vaginal hormone therapy after early breast cancer: a Danish observational cohort study |
|
|
| 2023-02-10 |
RE: Systemic or vaginal hormone therapy after early breast cancer: a Danish observational cohort study |
|
|
| 2023-02-10 |
Response to Pederson et al. and Chlebowski et al. |
|
|
| 2023-02-10 |
Premature aging as an accumulation of deficits in young adult survivors of pediatric cancer |
|
|
| 2023-02-10 |
Re: Obligate and Potential Precursors of Melanoma |
|
|
| 2023-02-10 |
Factors associated with timely COVID-19 vaccination in a population-based cohort of patients with cancer |
|
|
| 2023-02-10 |
Somatic inactivation of breast cancer predisposition genes in tumors associated with pathogenic germline variants |
|
|
| 2023-02-10 |
Speeding implementation in cancer: The National Cancer Institute’s Implementation Science Centers in Cancer Control |
|
|
| 2023-02-10 |
Polygenic risk of any, metastatic, and fatal prostate cancer in the Million Veteran Program |
|
|
| 2023-02-10 |
The Enhancing Oncology Model: Leveraging improvement science to increase health equity in value-based care |
|
|
| 2023-02-10 |
Breast cancer screening during the COVID-19 pandemic: moving from disparities to health equity |
|
|
| 2023-01-12 |
Correction to: Measuring Self-Reported Cancer-Related Cognitive Impairment: Recommendations From the Cancer Neuroscience Initiative Working Group |
|
|
| 2023-01-12 |
Use of Straighteners and Other Hair Products and Incident Uterine Cancer |
|
|
| 2023-01-12 |
Chemical Relaxers and Hair-Straightening Products: Potential Targets for Hormone-Related Cancer Prevention and Control |
|
|
| 2023-01-12 |
Addressing Transportation Insecurity Among Patients With Cancer |
|
|
| 2023-01-12 |
Food Insecurity Among People With Cancer: Nutritional Needs as an Essential Component of Care |
|
|
| 2023-01-12 |
Housing Insecurity Among Patients With Cancer |
|
|
| 2023-01-12 |
Addressing Social Determinants of Health: Now Is the Time |
|
|
| 2023-01-12 |
Unintended Negative Consequences of Managing Chemotherapy Toxicity |
|
|
